Alterations of lung microbiota in patients with non-small cell lung cancer

References

• Salloum RG, Braithwaite D. Expansion of guideline-recommended lung cancer screening eligibility: implications for health equity of joint screening and cessation interventions. J Thorac Oncol. 2022;17(1):13–15.
   PubMed Web of Science ®Google Scholar
• Zhang T, Joubert P, Ansari-Pour N, et al. Genomic and evolutionary classification of lung cancer in never smokers. Nat Genet. 2021;53(9):1348–1359.
   PubMed Web of Science ®Google Scholar
• Terzikhan N, Verhamme KMC, Hofman A, et al. Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study. Eur J Epidemiol. 2016;31(8):785–792.
   PubMed Web of Science ®Google Scholar
• Durham AL, Adcock IM. The relationship between COPD and lung cancer. Lung Cancer. 2015;90(2):121–127.
   PubMed Web of Science ®Google Scholar
• Collisson, EA , Campbell, JD , Brooks, AN et al. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511(7511):543–550.
   PubMed Web of Science ®Google Scholar
• Khatoon J. Role of Helicobacter pylori in gastric cancer: updates. World J Gastrointest Oncol. 2016;8(2):147–158.
   PubMed Web of Science ®Google Scholar
• Garrett WS. The gut microbiota and colon cancer. Science. 2019;364(6446):1133–1135.
   PubMed Web of Science ®Google Scholar
• Parida S, Wu S, Siddharth S, et al. A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and β-catenin axes. Cancer Discov. 2021;11(5):1138–1157.
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Marsland BJ. Lung homeostasis: influence of age, microbes, and the immune system. Immunity. 2017;46(4):549–561.
   PubMed Web of Science ®Google Scholar
• Jin C, Lagoudas GK, Zhao C, et al. Commensal microbiota promote lung cancer development via γδ T cells. Cell. 2019;176(5):998–1013.e16.
   PubMed Web of Science ®Google Scholar
• Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10(10):996–998.
   PubMed Web of Science ®Google Scholar
• Bolyen E, Rideout JR, Dillon MR, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852–857.
   PubMed Web of Science ®Google Scholar
• Chu DM, Ma J, Prince AL, et al. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat Med. 2017;23(3):314–326.
   PubMed Web of Science ®Google Scholar
• Jalili V, Afgan E, Gu Q, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2020 update. Nucleic Acids Res. 2020;48(W1):W395–w402.
   PubMed Web of Science ®Google Scholar
• Eapen MS, Hansbro PM, Larsson-Callerfelt A-K, et al. Chronic Obstructive Pulmonary Disease and Lung Cancer: underlying Pathophysiology and New Therapeutic Modalities. Drugs. 2018;78(16):1717–1740.
   PubMed Web of Science ®Google Scholar
• Shiels MS, Albanes D, Virtamo J, et al. Increased risk of lung cancer in men with tuberculosis in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev. 2011;20(4):672–678.
   PubMed Web of Science ®Google Scholar
• Carbone C, Piro G, Di Noia V, et al. Lung and gut microbiota as potential hidden driver of immunotherapy efficacy in lung cancer. Mediators Inflamm. 2019;2019:7652014.
   PubMed Web of Science ®Google Scholar
• Xiong K, Sun W, He Y, et al. Advances in molecular mechanisms of interaction between Mycobacterium tuberculosis and lung cancer: a narrative review. Transl Lung Cancer Res. 2021;10(10):4012–4026.
   PubMed Web of Science ®Google Scholar
• Chau J, Yadav M, Liu B, et al. Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer. BMC Cancer. 2021;21(1):808.
   PubMed Web of Science ®Google Scholar
• Reinhold L, Möllering A, and Wallis S, et al. Dissimilarity of airway and lung tissue microbiota in smokers undergoing surgery for lung cancer. Microorganisms. 2020;8(6):794. doi:10.3390/microorganisms8060794.
   Web of Science ®Google Scholar
• Tsay J-CJ, Wu BG, Sulaiman I, et al. Lower airway dysbiosis affects lung cancer progression. Cancer Discov. 2021;11(2):293–307.
   PubMed Web of Science ®Google Scholar
• Laroumagne S, Lepage B, Hermant C, et al. Bronchial colonisation in patients with lung cancer: a prospective study. Eur Respir J. 2013;42(1):220–229.
   PubMed Web of Science ®Google Scholar
• Peters BA, Hayes RB, Goparaju C, et al. The microbiome in lung cancer tissue and recurrence-free survival. Cancer Epidemiol Biomarkers Prev. 2019;28(4):731–740.
   PubMed Web of Science ®Google Scholar
• Greathouse KL, White JR, Vargas AJ, et al. Interaction between the microbiome and TP53 in human lung cancer. Genome Biol. 2018;19(1):123.
   PubMedGoogle Scholar
• Lee SH, Sung JY, Yong D, et al. Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions. Lung Cancer. 2016;102:89–95.
   PubMed Web of Science ®Google Scholar
• Dickson RP, Erb-Downward JR, Martinez FJ, et al. The microbiome and the respiratory tract. Annu Rev Physiol. 2016;78(1):481–504.
   PubMedGoogle Scholar
• Stasiewicz M, Karpiński TM. The oral microbiota and its role in carcinogenesis. Semin Cancer Biol. 2021. DOI:10.1016/j.semcancer.2021.11.002
   PubMed Web of Science ®Google Scholar
• Tsay J-CJ, Wu BG, Badri MH, et al. Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. Am J Respir Crit Care Med. 2018;198(9):1188–1198.
   PubMed Web of Science ®Google Scholar
• Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS One. 2010;5(1):e8578.
   PubMed Web of Science ®Google Scholar
• Liu Y, O’brien JL, Ajami NJ, et al. Lung tissue microbial profile in lung cancer is distinct from emphysema. Am J Cancer Res. 2018;8(9):1775–1787.
   PubMed Web of Science ®Google Scholar
• Nejman D, Livyatan I, Fuks G, et al. The human tumor microbiome is composed of tumor type–specific intracellular bacteria. Science. 2020;368(6494):973–980.
   PubMed Web of Science ®Google Scholar
• Eftekhari R, De Lima SG, Liu Y, et al. Microenvironment proteinases, proteinase-activated receptor regulation, cancer and inflammation. Biol Chem. 2018;399(9):1023–1039.
   PubMed Web of Science ®Google Scholar
• Van Spaendonk H, Ceuleers H, Witters L, et al. Regulation of intestinal permeability: the role of proteases. World J Gastroenterol. 2017;23(12):2106–2123.
   PubMed Web of Science ®Google Scholar
• Gowing SD, Chow SC, Cools-Lartigue JJ, et al. Gram-positive pneumonia augments non-small cell lung cancer metastasis via host toll-like receptor 2 activation. Int J Cancer. 2017;141(3):561–571.
   PubMed Web of Science ®Google Scholar
• Gowing SD, Chow SC, Cools-Lartigue JJ, et al. Gram-negative pneumonia augments non–small cell lung cancer metastasis through host toll-like receptor 4 activation. J Thorac Oncol. 2019;14(12):2097–2108.
   PubMed Web of Science ®Google Scholar
• Millares L, Pérez-Brocal V, Ferrari R, et al. Functional metagenomics of the bronchial microbiome in COPD. PLoS One. 2015;10(12):e0144448.
   PubMed Web of Science ®Google Scholar
• Zheng X, Liu R, Zhou C, et al. ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of Fusobacterium nucleatum in Colorectal Cancer. Cancer Res. 2021;81(24):6157–6170.
   PubMed Web of Science ®Google Scholar